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In all organisms, genes exist that encode for regulatory proteins, called 
transcription factors (TFs), that can activate or repress transcription of specific genes 
depending on their biological function. Thermus thermophilus HB8 is speculated to 
contain 2,245 genes, of which 70 are postulated to be transcription factors. However, but 
for very few, little is known regarding the genes they regulate and their biological 
functions. The novel combinatorial method Restriction Endonuclease Protection, 
Selection, and Amplification (REPSA) has successfully identified and validated 
consensus binding sequences in T. thermophilus HB8 with previously studied TFs. Here 
REPSA was explored as a technique and method for characterizing TTHA1437 and 
TTHA1719 TFs in T. thermophilus HB8. TTHA1437 REPSA results showed a promising 
DNA selection, but the results were not reproducible. Contrarily, TTHA1719 REPSA 
results did not show any selected DNAs, but during REPSA selections, a rare DNA 
species, the asterisk species, was observed. REPA results for TTHA1437 showed 
nonspecific binding, and TTHA1719 results showed no validation. EMSA also exhibited 
no DNA-ligand complex formation for both TFs. From the literature, a proposed potential 
consensus DNA for TTHA1719 proved promising with initial REPAs, and possible 
homologous DNA-binding consensus sequences for TTHA1437 and E. coli CRP were 
explored. Unfortunately, these were ultimately unsuccessful. These results demonstrate 
that REPSA is not a viable method to characterize all TFs and prompted us to explore 
why REPSA does not work for these T. thermophilus HB8 TFs and how it could be 
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improved. One possible improvement could entail more extensive preliminary DNA-
binding assays with potential DNA-binding site(s) before embarking on REPSA 
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Chapter 1.1 Bacterial Transcription Factors 
 
The vast amount of sequence data presently available on whole genomes 
(eukaryotic and prokaryotic) is staggering since the Human Genome Project (HGP) was 
completed in 2003, the price of sequencing technologies has significantly decreased thus 
allowing for affordable in-house  Next Generation Sequencing (NGS).1 Although many 
genomics, transcriptomics, and metabolomics data have been obtained since the 
completion of the HGP, the biological functions of many genes are still unknown and 
therefore are unable to be assigned. Thus, scientists turn to one of the simpler organisms 
in life, prokaryotes.2 Despite the fact that eukaryotic organisms are genetically more 
diverse than prokaryotic organisms, there are in fact prokaryotes which are model 
organisms for understanding the biological functions of genes, as well as gene 
regulation.3,4 Some well-known model prokaryotes include Escherichia coli (E. coli), 
Pseudomonas aeruginosa (P. aeruginosa), and Thermus thermophilus (T. thermophilus).5 
An extremely important cellular process throughout all organisms of life, 
transcription, converts the information encoded in the genome (DNA) to messenger RNA 
(mRNA), transfer RNA (tRNA), or ribosomal RNA (rRNA)6. The central dogma of 
molecular biology describes the flow of genetic information, DNA→RNA→protein. 
Without gene expression, cells would be unable to express proteins and therefore unable 
to perform even basic cellular functions. The transcription process is highly regulated, in 
part by proteins called transcription factors (TFs).7 Without control by TFs there would 
be unnecessary transcripts being transcribed and necessary transcripts not being 
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transcribed, both outcomes are detrimental. TFs are an organism’s key to gene 
regulation; either activating or repressing genes of interest during the initiation of 
transcription.8 Transcription factors regulate gene expression by interacting with 
promoter and/or enhancer elements upstream of the transcriptional start site. When they 
interact with these regulatory elements the gene of interest can be repressed or 
activated.8,9 Transcriptional repressors block RNA Polymerase (RNAP) holoenzyme 
from binding promoter DNA, and therefore repressing transcription. In contrast, 
transcriptional activators recruit RNAP holoenzyme which then increases the frequency 
of transcription.10,11 Although many TFs have been identified and characterized in E. coli 




Chapter 1.2 Types of Transcriptional Regulators 
 
A classic and extremely well characterized model for gene regulation is the lac 
operon in Escherichia coli which is involved in lactose metabolism.12 The lac operon 
contains a single promoter region and consists of three structural genes denoted lacZ, 
lacY, and lacA which encode for β-galactosidase, galactoside permease, and galactoside 
acetyltransferase respectively. Although these genes are regulated in parallel, galactoside 
acetyltransferase does not play a major role in lactose metabolism.12 Upstream of the 
structural genes, there exists a catabolite activator protein (CAP) binding site, a promoter, 
and an operator region which are involved in the regulation of the lac operon; therefore, 
transcription can be activated or repressed. 
Transcription is initiated at the promoter site which is located just upstream of the 
structural gene lacZ. In the event that cellular concentrations of glucose are high and that 
lactose is unavailable, a repressor protein will bind to the operator region and the lac 
genes will not be expressed.12,13 Contrarily, positive transcription control will occur if the 
cellular concentration of glucose is low and lactose is high. When glucose levels are low, 
levels of cAMP are high and readily bind with the catabolite activator protein (CAP).13 
Once the CAP-cAMP complex is formed, the transcriptional activator binds DNA within 
the promoter region and allows robust expression of the lac genes. The positive and 
negative regulation of the lac operon is extremely important for cells to adequately 
respond to environmental changes and stressors.14,15 
CRPs, also known as catabolite activator proteins (CAPs), tend to be homologous 
throughout many organisms due to their similar amino acid residues, structural similarity, 
and helix-turn-helix (HTH) motifs.16 The HTH motif, two α-helices joined by a short 
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loop of amino acids, is extremely important for DNA-binding proteins, especially 
transcription factors.17 Many HTH proteins bind to DNA in a dimer fashion and 
recognize palindromic sequences as their DNA-binding domain (DBD).17,18 Similarly, 
other DNA-binding proteins (e.g. restriction endonucleases), recognize palindromic DNA 
sequences, which is important for their cleavage specificity. Although there are proteins 
that recognize non-palindromic sequences, the majority of regulatory proteins prefer 
palindromic sequences such as the CRP global regulator in E. coli.19 
In Escherichia coli there exists a set of transcription factors which are involved in 
the regulation of multiple genes when a cellular stress-response is activated. Interestingly, 
one of these TFs is the E. coli cAMP receptor protein (CRP); this CRP is a global 
regulator within E. coli due to the sheer number of genes this transcription factor 
regulates.19,21 One unique property of E. coli CRP is its ability to act as an activator, 
repressor, coactivator and corepressor. This unique property, along with the different 
classes of promoters it recognizes, permits CRP to regulate a tremendous amount of 
Escherichia coli’s genome.21 Although it only directly regulates the transcription of ~300 
of the ~4500 genes (depending on the strain), the E. coli CRP indirectly regulates gene 
expression of about half the genome.22 
Global regulators and local regulators are defined by the number and the function 
of the genes they regulate. Global TFs regulate many operons with different metabolic 
functions, while local TFs regulate single gene pathways or operons which belong to the 
same functional classification. Interestingly, global regulators can interact with local 
regulators to form a co-regulation mechanism which can in turn lead to a feedback loop 
which can widely influence gene expression22. Although a vast amount of information is 
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known about the Escherichia coli CRP global gene regulator, there is very little 
knowledge available about the homologous Thermus thermophilus CRP, TTHA1437. 
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Chapter 1.3 Identification and Characterization of TFs in Thermus thermophilus HB8 
In the past, the Van Dyke laboratory has used REPSA to identify 
transcriptional regulators in the extreme thermophile and model organism Thermus 
thermophilus HB8. This gram-negative, rod shaped, aerobic bacterium was first isolated 
from a Japanese hot spring in 1968 and can grow in temperatures ranging from 50°C to 
82°C, with its optimal growth temperature being between 65°C and 72°C.23,24 Although 
there are two well-studied strains of T. thermophilus, HB8 and HB27, our focus is on the 
HB8 strain given that it is the model organism for the Structural-Biological Whole Cell 
Project at the RIKEN Institute in Japan.25 The Whole Cell Project aims to understand all 
biological phenomena within T. thermophilus HB8 at an atomic level through the 
determination of three-dimensional structures for all of its proteins. To date, the 
Structural-Biological Whole Cell Project has purified 944 T. thermophilus HB8 proteins 
and 682 of these have been crystallized.25 
The genome of the HB8 strain consists of a ~1.85 Mbp circular chromosome 
(TTHA), a mega plasmid of ~0.26 Mbp (TTHB), and a mini plasmid of ~9.3 kbp 
(TTHC).25 The difference between the genome of HB8 and HB27 is that HB8 has the 
addition of the mini plasmid, TTHC, which gives the HB8 strain a unique advantage as a 
facultative anaerobe versus an obligate anaerobe (HB27). The transcription factors of 
interest for this study are located on the circular chromosome and denoted TTHA1437 
and TTHA1719. TTHA1437 is 23,819 Daltons (Da) in mass and is suspected to belong to 
the CRP family of activators in T. thermophilus HB8 including TTHA1437, TTHA1567 
and TTHB099 due to their homology within the E. coli CRP global regulator.20,26,27 
TTHA1719 is a transcriptional repressor with a mass of 10,858 Da and is suspected to be 
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a copper homeostasis operon regulatory protein due to its homology with CsoR from M. 
tuberculosis and B. subtilis.28 
8 
 
Chapter 1.4 Significance of Restriction Endonuclease Protection, Selection, and 
Amplification for Identifying Preferred DNA-Binding Sites 
Restriction Endonuclease Protection, Selection, and Amplification (REPSA) is a 
novel combinatorial method developed by the Van Dyke laboratory. This is an in vitro 
PCR-based technique that utilizes a pool of randomized DNA sequences to select for TF-
DNA interactions. When a type IIS restriction endonuclease (IISRE) is introduced, any 
uncomplexed DNAs will be cleaved and intact templates will be PCR amplified to 
further select for a DNA-binding sequence. One of the key components of the REPSA 
selection method is the DNA selection template which is derived from the ST2R24 or 
ST2R35 template precursors (Figure 1A and 1B). Both selection templates are composed 
of a 23-mer (ST2L) primer on the 5’ end and a fluorescently red-labeled 25-mer 
(IRD7_ST2R) primer on the 3’; both primers flank the internal randomized region (either 
24-mer or 35-mer, respectively). The IRD7_ST2R primer was specifically designed to 
contain the binding/recognition sites for two different type IIS restriction endonucleases: 
FokI (CATCC) and BpmI (CTCCAG).29 
 
Figure 1A. REPSA selection templates ST2R24 and ST2R35. A 
depiction of the ST2R24 REPSA selection template and its components 
(ST2R35 not pictured). ST2L and IRD7_ST2R primers are denoted by 
horizontal arrows, (N) denotes random nucleotides within the 
randomized region (only difference between ST2R24 and ST2R35 are 
N=24 or N=35), and the brackets and small arrows denote the 





Type IISREs are unique compared to other restriction endonucleases since they 
bind asymmetric dsDNA at a specific sequence (recognition domain) but cleave at a 
fixed distance away (cleavage domain); this distance varies for different IISREs. These 
types of restriction endonucleases are useful for many applications in molecular biology 
such as gene cloning and DNA fragmentation.30 IISREs also allow the probing of a 
randomized region to select for sequences that specifically bind a DNA- binding ligand 
(e.g., transcription factor). This unique characteristic allows REPSA selections to work 
for a variety of different DNA-binding molecules (e.g. drugs, multiplex DNAs, 
proteins).31 
The novel combinatorial method Restriction Endonuclease, Protection, Selection, 
and Amplification (REPSA) is a PCR-based method used to identify and characterize 
nucleic acid-protein interactions. REPSA experiments utilize the ST2R24 DNA selection 
template, IISREs, and a ligand of interest; in our case TTHA147.29 A schematic for 
REPSA selection is shown in Figure 2. Here, the black regions represent the known 
flanking regions of the template while the red region represents the internal randomized 
region.29,32,33 Once the ligand is introduced (green) it will bind to any preferred 
sequences that are present in the DNA pool. Due to the varying templates in the 
selection pool, the ligand will initially have very few templates to bind to. Thus, this 
selection method requires multiple rounds to identify a preferred DNA-binding site.  
Once the ligand has been introduced to the selection templates, a IISRE is then 
introduced and any template with a ligand bound will not be cleaved, yet all unbound 
templates will be cleaved. An aliquot of the experimental reaction (DNA+IISRE+ligand) 
is then subjected to polymerase chain reaction (PCR), amplifying the selection templates 
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in 6, 9, and 12 cycles. The PCR reaction will not amplify any DNAs that have been 
cleaved, thus selecting for protected templates.29 
During a round of REPSA, there are three reactions that run in parallel. The first 
being a control: DNA template, no IISRE, and no ligand (-/-). The second reaction is also 
a control, but a cleavage control: DNA template, IISRE, and no ligand (-/+). The third 
and most important reaction is the binding reaction: DNA template, IISRE, and 
TTHA1437. These reactions and the subsequent PCRs are visualized using 10% native 
PAGE and IR fluorescence to determine how much selection has occurred. The dsDNA 
concentration of the DNA pool is also quantified using a Qubit assay. Sequential rounds 






Figure 2. The REPSA method. A diagram depiction of restriction endonuclease 
protection, selection, and amplification (REPSA) and all the components included. 
The DNA selection template pool is symbolized by the black (primers) and red (24- 
or 35-mer randomized region). The ligand (TTHA1437 or TTHA1719) is shown in 
green, and the IISRE is shown in brown. The first step is the introduction of the 
ligand to the template pool at which time only a small percentage of DNAs will be 
bound to the ligand (complex formation step). The second step introduced a IISRE 
(either FokI or BpmI) which will cleave all DNA templates that are unbound by the 
ligand. After, this reaction will be subjected to PCR amplification but only the 
protected DNA species will amplify which further selects for the preferred DNA-
binding sequence. Finally, the amplified DNAs will be used as the input for the next 
round of REPSA; subsequent rounds of REPSA will typically result in a selected 
DNA sequence which is ligand specific.  
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In Figure 3, rounds 1 and 7 of REPSA selections are shown for another T. 
thermophilus transcriptional regulator, SbtR, that has been previously studied.32 Due to 
self-inhibitory cleavage by certain IISREs, the restriction endonuclease was switched 
from FokI to BpmI between rounds 4 and 5. In round 7, ~50% cleavage resistance due to 
sequence selection occurred, thus validating that this selection method is feasible, so the 















Figure 3. Expected REPSA results. Shown are IR fluorescence images of restriction 
endonuclease cleavage-protection assays for Round 1 and Round 7 of REPSA 
selections with SbtR protein. Reactions in lane 1 represents the DNA control (+/-), 
lane 2 being the cleavage control containing the DNA template and IISRE (-/F or -/B 
to represent FokI and BpmI IISREs respectively), and lane 3 is the experimental 
reaction containing DNA template, IISRE, and SbtR (+/F or +/B). Band designations: 
(T) intact ST2R24 selection template, (X) cleaved ST2R24 selection template, and (P) 
IRD7_ST2R primer. This image has been adapted from Figure 4 in Reference 32. 
 
Once a pool of protected DNA templates has been selected, it is important to 
validate that the selection contains bona fide DNA-binding sites. It is important to 
validate the experimental results before sequencing due to the occurrence of non-specific 
binding artifacts. One validation experiment is Restriction Endonuclease Protection 
13 
 
Assay (REPA) which is similar to REPSA but, does not include the amplification step. 
An example is shown in Figure 4A for the previously studied SbtR.32 REPA validations 
require a known DNA control (REPSAis) and the experimental REPSA DNA. Since 
TTHA1437 requires the effector molecule 3’,5’-cyclic adenosine monophosphate 
(cAMP), REPA will be the preferred method for validating the selection. Another 
validation experiment is Electrophoretic Mobility Shift Assay (EMSA), also called a gel 
shift assay, which is an extremely common technique used to determine nucleic acid- 
protein interactions (Figure 4B).33,34 Although EMSA is an important nucleic acid-ligand 
assay, if the protein of interest requires an effector molecule it is not the most effective 
method to validate a REPSA selection. Both REPA and EMSA methods should be viable 
to validate TTHA1719 REPSA-selected DNAs since it is not known to require an 
effector molecule to repress transcription.28 
 
 
Figure 4. Traditional methods used to validate REPSA results. (A) Shown are LICOR 
images of IRD7-labeled SbtR consensus DNA (red) and IRD8-labeled REPSAis control 
DNA (green) subjected to BpmI cleavage following binding reactions in the presence of 
(left to right) 0, 1, 10, 100, 1000 nM dimer SbtR protein. (C) Uncleaved DNA control 
lane. (T) intact, uncleaved DNA, (X) cleaved DNA. (B) Shown are LICOR images of 
EMSAs containing pooled DNA from either Round 1 (left lanes) or Round 5 (right 
lanes) of REPSA selection and increasing concentrations of FadR protein (from left to 
right: 0, 0.6, 6, 60, or 600 nM FadR). The electrophoretic mobility of a single protein-
DNA complex (S) as well as uncomplexed ST2R24 selection template (T) and 
IRD7_ST2R primer (P) are indicated at right of figure. These figures have been adapted 
from Figures 7 and Figure 2 from References 32 and 33 respectively. 
14 
 
Chapter 1.5 Investigation of Known and Proposed Consensus DNAs 
 
For both T. thermophilus HB8 transcription factors in these studies, TTHA1437 
and TTHA1719, there have been proposed potential consensus DNAs for their DNA- 
binding sites.26,28 One of the problems that arises from these proposed consensus DNAs is 
that little, if any, binding assays were performed with their proposed consensus 
sequence(s). Although bioinformatic approaches can be extremely useful for determining 
possible ligand-nucleic acid analyses, it is important to test the findings of these 
bioinformatic studies to determine if it is in fact a true DNA-binding site. In order to 
validate these findings, it was important for us to investigate these proposed consensus 
sequences via different binding assays (REPA and EMSA). Furthermore, the DNA- 
binding consensus sequence for E. coli CRP was of interest in this study since 
TTHA1437 is a supposed homolog and belonging to the CRP/FNR group in T. 
thermophilus. The E. coli CRP consensus DNA-TTHA1437 interactions were to be 
investigated using EMSA and BLI.22 The sequences of these known and proposed 
consensus DNAs can be found in Table 1. 
15 
 
Chapter 1.6 Hypothesis and Specific Aims 
 
A reverse genetic approach can be used to identify and characterize T. 
thermophilus HB8 transcriptional regulators TTHA1437 and TTHA1719 and possible 
ascertain their biological functions. 
1. Express and purify the proteins of interest, TTHA1437 and TTHA1719. 
 
2. Use Restriction Endonuclease Protection, Selection, and Amplification (REPSA) 
to identify preferred DNA-binding sequences for TTHA1437 and TTHA1719. 
3. Validate the REPSA selections via REPA, EMSA, and BLI. 
 
4. Perform binding assays (REPA, EMSA, BLI) with proposed potential consensus 
DNAs and known consensus DNAs. 
5. Analyses of results and bioinformatic studies, if REPSA-selected DNAs are 























MATERIALS AND METHODS 
 
Chapter 2.1 Oligonucleotides and Selection Template Preparation 
 
The oligonucleotide precursors and primers used in these studies were synthesized 
and purified by Integrated DNA Technologies and are listed in Table 1. Two different 
selection templates, ST2R24 and ST2R35, were PCR amplified to create double-stranded 
DNA libraries for both templates. Each template was designed so the randomized cassette 
regions have an average nucleotide composition of 25% A, 25% T, 25% C, and 25% G at 
each position. Preparation of the ST2R24 template involved five 25 µL reactions in 
which each contained 1 ng single-stranded ST2R24 precursor DNAs, 1X Standard Taq 
Reaction Buffer (New England Biolabs, NEB), 560 nM ST2L primer, 560 nM 
IRD7_ST2R primer, 50 µM dNTPs, and 25 U Taq DNA Polymerase. These reactions 
were PCR amplified with the cycling conditions comprising of 5 cycles of 95°C for 30 
sec, 60°C for 30 sec, and 68°C for 1 min; 1 cycle of 95°C for 30 sec, 60°C for 30 sec, and 
68°C for 1.5 min; the final cycle of 95°C for 30 sec, 60°C for 30 sec, and 68°C for 2 min. 
The ST2R35 template was prepared in a similar manner to ST2R24 although the 
reaction and cycling conditions differed slightly. Preparation of ST2R35 comprised of 
three 25 µL reactions with each containing 1 ng single-stranded ST2R35 precursor 
DNAs, 1X Standard Taq Reaction Buffer (NEB), 200 nM ST2Ls primer, 200 nM 
IRD7_ST2R primer, 200 µM dNTPs, and 12.5 U Taq DNA Polymerase. Cycling 
conditions involved 6 cycles of 95°C for 30 sec, 58°C for 1 min, and 68°C for 1.5 min. 
Although the construction of these selection templates differs, this allows for the 
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maximum amount of DNAs that contain a fully annealed random cassette region as well 
as increasing the diversity in the randomized region of the selection template. 
The ST2_1437_jcon probe was prepared using a standard NEB PCR protocol for 
Taq DNA Polymerase which included 1 ng ST2_1437_jcon DNA, 1X Standard Taq 
Reaction Buffer, 200 nM ST2L primer, 200 nM IRD7_ST2R primer, 200 µM dNTPs, 
and 1.25 U Taq DNA Polymerase. The ST2_CRP_Ec probe was prepared in the same 
fashion as ST2_1437_jcon but 1 ng ST2_CRP_Ec was used instead. Cycling conditions 
consisted of 30 cycles of 90°C for 30 sec, 58°C for 30 sec, and 68°C for 1 min. The 
ST2_1719_jcon-60 and REPSAis probes were both prepared in the same fashion utilizing 
a fusion PCR protocol which involved two consecutive PCR amplifications. The first 
fusion PCR step mimics those of the ST2_1437_jcon preparation with 1 ng DNA 
template, ST2_1719_jcon-60 or REPSAis (ST2R_1719 and ST2Ls or trP1_ST2L and 
ST2R primers), but the samples were amplified for 6 cycles vs 30. After 6 rounds of 
amplification, 2 µL of the initial PCR was used to seed the next reaction containing 1X 
Standard Taq Reaction Buffer, 200 µM dNTPs, and 1.25 U Taq DNA Polymerase. For 
the ST2_1719_jcon-60 probe, 200 nM IRD7_ST2R and 200 nM ST2Ls primers were 
used and for REPSAis 200 nM IRD8_trP1_ST2L and 200 nM ST2R primers; both were 
amplified for 30 cycles as previously described. The REPSAis probe was used as an 
internal standard to determine if DNA-protein interactions are specific vs. nonspecific. 
18 
 
Table 1. Oligonucleotides used in these studies. 
 

























ST2L CTAGGAATTCGTGCAGAGGTGAAT 24 Desalt PCR Left Primer 
ST2Ls CTAGGAATTCGTGCAGAGGTGA 22 Desalt PCR Left Primer Short 
ST2R GTCCAAGCTTCTGGAGGGATGGTAA 25 Desalt PCR Right Primer 
IRD7_ST2R /5IRD700/GTCCAAGCTTCTGGAGGGATGGTAA 25 HPLC 5’-IRDye700 PCR Primer 
ST2R_1719 GTCCAAGCTTCTGGAGGGATGTACCCCA 28 Desalt Fusion PCR Primer 




































Bio_ST2R /5BiodT/GTCCAAGCTTCTGGAGGGATG 22 HPLC 5’-biotinylated PCR primer 
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Chapter 2.2 Protein Preparation of TTHA1417 and TTHA1719 
 
E. coli BL21 (DE3) competent cells were transformed with the pET-11a plasmid 
which contained the TTHA1437 gene of interest. Once transformed, the cells were 
inoculated in Super Optimal Broth (SOB) media containing 100 µg/mL ampicillin and 
incubated at 37°C/250 rpm. The culture was induced with isopropyl β-D-1- 
thiogalactopyranoside (IPTG; 1 mM final concentration), incubated at 37°C/250 rpm for 
4 hours to an OD600 of 0.651 and centrifuged to pellet the bacteria. The bacterial pellet 
was resuspended with 2X BEB (40 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.2 mM EDTA, 
2 mM DTT, 1 mM PMSF) and stored at -20°C. Lysozyme was added to the thawed, 
resuspended sample to a final concentration of 0.25 µg/µL and incubated for 5 min at 
0°C. The cells were then subjected to 5 rounds of sonication (3 W/cm2, 10 sec on/10 sec 
off, 0°C) to lyse the cells and centrifuged (10 min, 13,000 rpm, 4°C) to pellet debris. 
Following the steps above, the resulting supernatant was subjected to a simple 
heat treatment for 15 min at 70°C to purify TTHA1437. This purification method is 
extremely simple as the mesothermic E. coli proteins denature at 70°C while the 
thermophilic T. thermophilus proteins do not. Once purified, the sample was centrifuged 
(15 min, 13,000 rpm, 4°C). The supernatant was diluted in an equal volume of glycerol 
and rocked for 1 hour at 4°C to ensure a homogenous TTHA1417 protein stock for 
downstream experiments. Purified TTHA1417 was stored at -20°C. The purity of 
TTHA1437 was determined using 12% SDS-PAGE and its concentration was quantified 




TTHA1719 was prepared in a similar manner to TTHA1417, with the following 
alterations that allowed optimal protein expression. Due to the rare codon usage of 
TTHA1719, RosettaTM 2 (DE3) E. coli competent cells were transformed with the 
pTTHA1719 plasmid. 4 samples were then inoculated in 1 mL Lysogeny broth (LB) 
media in the presence of 100 µg/mL ampicillin and 35 µg/mL chloramphenicol and 
incubated at 37°C/250 rpm. After 1 hour, the two cloudiest cultures were transferred to 
50 mL LB media in the presence of 100 µg/mL ampicillin and 35 µg/mL 
chloramphenicol, antibiotics required for the maintenance of plasmids. These samples 
were incubated at 37°C/250 rpm for 5 hours before 0.5 mL IPTG (1 mM final 
concentration) was added to the second sample (sample 1 was used as the uninduced 
control). Both samples were incubated at 37°C/250 rpm for 4 hours until the induced 
culture had an OD600 of 0.818 and the uninduced an OD600 of 
1.23. These were centrifuged (15 min, 4,500 rpm, 4°C), the supernatant decanted, 
resuspended in 500 mL 2X BEB, and stored at -20°C until the purification process. 
The samples were thawed and resuspended before 30 µL lysozyme (0.25 µg/µL 
final concentration) was added and incubated for 10 min at 0°C, mixing once halfway 
through. The cells were then subjected to 5 rounds of sonication (2.5 W/cm2, 10 sec 
on/30 sec off, 0°C) and centrifuged (15 min, 13,000 rpm, 4°C). The supernatant was 
subjected to heat treatment at 70°C for 15 min, mixing halfway through, and centrifuged 
(15 min, 13,000 rpm, 4°C). An equal volume of glycerol was added to the supernatant 
and rocked (30 min, 4°C) to ensure proper mixing and was stored at -20°C for further 
use. The purity of TTHA1719 was determined similarly to TTHA1437 with the 
difference being an 18% SDS-PAGE containing 4 M urea. Due to the low molecular 
weight of TTHA1719, a traditional 12% SDS-PAGE would be ineffective. The 
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concentration of TTHA1437 was determined using a Bradford Protein Assay and the 
concentration of TTHA1719 was determined by Quantitative Densitometry with 
Coomassie; both of these assays use BSA as a standard. Although some E. coli and 
lysozyme proteins are still present, they have not interfered with or affected previously 
studied T. thermophilus TFs due to their denatured state and significant dilution of 
TTHA1437 and TTHA1719 in future experiments. 
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Chapter 2.3 REPSA Selection Method 
 
REPSA selections for TTHA1437 were performed in 20 µL reactions with 4.515 
ng (100 fmol) ST2R24 DNA template in 1X CutSmart® Buffer (NEB; 50 mM Potassium 
Acetate, 20 mM Tris-acetate, 10 mM Magnesium Acetate, 100 µg/mL BSA, pH 7.9 at 
25°C) and 20 µM 3’,5’-cAMP. The first round of REPSA utilized the initial ST2R24 
DNA library, while successive REPSA sounds were seeded with 2 ng DNA from the 
previous round of REPSA. Each round of REPSA includes three reactions run in tandem: 
the DNA control, IISRE control, and the experimental reaction which contains the ligand 
of interest (-/-, -/IISRE, and +/IISRE). The DNA and IISRE controls contained 1-3 µL 
PDB (20 mM Tris HCl, 100 nM NaCl, 0.1 mM EDTA, 1 mM DTT, 100 µg/mL BSA, 
0.1% Tween 20, pH 8.0 at 25°C) respectively, while the experimental reaction was 
incubated with 30.9 nM monomeric or 15.45 nM dimeric TTHA1437 protein diluted in 
PDB. Once assembled, these reactions were incubated at 55°C for 20 min to facilitate 
DNA-ligand interactions and then equilibrated at 37°C for 5 min. After equilibration, the 
IISRE control and experimental reactions were treated with 0.8 U FokI and 4 U BpmI 
REases for rounds 1-3 and 4-6 and incubated at 37°C for 5 min to cleave any unbound 
DNA species. The reactions were then placed on ice to cease endonuclease activity. 
Rounds of REPSA for TTHA1437 were also completed in a similar fashion, but without 
the addition of cAMP to determine if TTHA1437 does or does not require cAMP for 
DNA interactions to occur. 
REPSA selections for TTHA1719 were performed in 10 µL reactions with 3.896 
ng (75 fmoles) ST2R35 DNA selection template. The differences in REPSA selections 
for TTHA1719 include the addition of 1 mM DTT as a reducing agent and 41.6 nM 
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monomeric, 20.8 nM dimeric or 10.4 nM tetrameric TTHA1719 protein. Also, 0.8 U 
FokI and 4 U BpmI restriction endonucleases were used for rounds 1-2 and 3-11 
respectively and incubated for 10 min to allow for maximum cleavage of unbound DNAs. 
All other aspects of these selections follow formerly outlined REPSA protocols. 
After each round of REPSA, an amplification step is required before continuing 
on to another round of selections. Each amplification step utilized three 23 µL reactions 
which contained 1X NEB Standard Taq Reaction Buffer (NEB), 200 µM dNTPs, 200 nM 
ST2L or ST2Ls primer, 200 nM IRD7_ST2R primer, and 3.5 U Taq DNA Polymerase. 2 
µL of the REPSA experimental reaction was added to each before PCR amplification. 
The reactions were then amplified for 6, 9, and 12 cycles utilizing the following cycling 
conditions: denaturation at 95°C for 30 sec, annealing at 58°C for 1 min, and elongation 
at 68°C for 1 min (1.5 min for ST2R35). After PCR amplification, 2 µL from each PCR 
reaction were combined with 2 µL 6X Orange Loading Dye (20% wt/vol dextrose, 0.9% 
wt/vol Orange G, 1% wt/vol SDS, and 66 mM EDTA). 
REPSA reactions and the 6, 9, 12-cycle DNAs were run on a 10% wt/vol Native 
PAGE in 0.5X TBE for 10 min at 54V and then 55 min at 108V. Following gel 
electrophoresis, the results were imaged and visualized by LI-COR Odyssey Imager and 
the DNA concentrations of the amplified species were measured by Qubit 3 Fluorometer 
following the manufacturers protocol and reagents. 
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Chapter 2.4 Validation of REPSA Selections via Binding Assays 
The selected DNA sequences from REPSA were subjected to Restriction 
Endonuclease Protection Assay (REPA) to validate the selections. REPA is similar to 
REPSA, but with the addition of the REPSAis control DNA and this assay does not 
include an amplification step. REPA 10 µL reactions were performed with 1X Cutsmart 
Buffer, 2 ng REPSA-selected DNAs (Round 6 for TTHA1437 and Round 11 for 
TTHA1719), 2 ng REPSAis control DNA, the respective transcription factor (TTHA1437 
or TTHA1719), and the IISRE BpmI (4 U). REPA for TTHA1437 required 20 µM cAMP 
and TTHA1719 required 1 mM DTT. Reactions were incubated at 55°C for 20 minutes 
and then 37°C for 5 minutes before introducing 4 U BpmI and incubating for another 5- 
10 min at 37°C. 2 µL of each REPA reaction were mixed with 2 µL 6X Orange Loading 
Dye and run on a 10% wt/vol polyacrylamide (19:1 acryl:bis) gel at 54V for 10 min and 
108V for 55 min before visualizing results by IR fluorescence. 
Another validation method used was Electrophoretic Mobility Shift Assay 
(EMSA). EMSA 5 µL reactions were also performed with 2 ng Round 6 REPSA-selected 
DNA, PDB, 20 µM cAMP, and 1 µL TTHA1437 with ten-fold serial dilutions (0, 3.09, 
30.9, 309, and 3,090 nM). The reactions were incubated at 55°C for 5 minutes to 
equilibrate prior to the addition of TTHA1437. After the addition of protein, the reactions 
were incubated at 55°C for 30 minutes to facilitate DNA-protein complex formation. 2 
µL 6X Orange Loading Dye without SDS (20% wt/vol dextrose, 0.9% wt/vol Orange G, 
and 66 mM EDTA) was added to the EMSA samples prior to gel electrophoresis. The 
samples were run on a 0.5X TAE, 10% polyacrylamide gel and run in 0.5X TAE buffer 
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for 10 min at 54V and then 55 min at 108V. The results were visualized using the LI- 
COR Odyssey Imager as previously described. 
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Chapter 2.5 Binding Assays with Japanese Consensus Probes and E. coli Consensus 
Probe 
Following REPSA selections for TTHA1437 and validation using REPA and 
EMSA, the Japanese consensus DNA for TTHA1437 was used in REPA and BLI. 
Similarly, the E. coli CRP consensus DNA was used in EMSA and BLI since TTHA1437 
is a supposed orthologous TF to that of E. coli CRP. The REPA followed a similar 
protocol as previously described with 10 µL reactions containing 2 ng REPSAis control 
DNA, 2 ng ST2_1437_jcon DNA probe, 1X Cutsmart Buffer, and 20 µM cAMP. 
Reactions were incubated at 55°C for 20 min and then 37°C for 5 min to equilibrate 
reactions before the addition of 0.8 U FokI and a final incubation for 5 min at 37°C. 
Results were visualized by IR fluorescence as previously described. The EMSA done 
using the E. coli CRP consensus DNA was performed using the same protocol as 
previously outlined with the only difference being the DNA template (ST2_CRP_Ec vs 
REPSA selected DNAs) and dimeric TTHA1437 protein concentrations of 3.09, 9.27, 
27.81, 83.43, and 250.29 nM. 
Real-time binding kinetics were determined by biolayer interferometry (BLI) 
using biotinylated ST2_1437_jcon DNAs and TTHA1437. Biotinylated DNAs were 
prepared by PCR amplification in 50 µL reactions containing 1X Standard Taq Reaction 
Buffer, 50 µM dNTPs, 350 nM ST2L primer, 300 nM Bio_ST2R primer, 2 U Taq DNA 
Polymerase and 2 ng DNA template (ST2_1437_jcon or ST2_CRP_Ec consensus 
DNAs). Cycling conditions consisted of 30 cycles of 95°C for 30 sec, 58°C for 30 sec, 
and 68°C for 1 min. The BLI assays were performed with a FortéBio OctetQK instrument 
in 96-well microplates using Streptavidin Biosensors (FortéBio) and biotinylated DNAs 
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prepared as previously described. Each BLI assay consisted of four lanes by four rows 
and each well contained 200 µL reactions which were buffered with BLI 100 Buffer 
supplemented with cAMP (20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.05% Tween 
20, 20 µM cAMP, pH 7.7 at 25°C). The loading step consisted of 2 nM biotinylated 
DNAs, the background and dissociation steps consisted of 200 µL BLI 100 Buffer w/ 
cAMP, and the association step contained four concentrations of TTHA1437 (11, 33, 
100, and 300 nM), respectively. Binding kinetics were determined using association and 
dissociation data and non-linear regression analyses in GraphPad Prism 8. 
Unlike the binding assays for TTHA1437 using known DNA templates which 
were performed after REPSA selections, the binding assays for TTHA1719 and 
ST2_1719_jcon-60 were completed prior to REPSA selections in order to determine not 
only if binding occurs but also to determine the optimal protocol conditions to be used in 
REPSA selections. The first REPA was followed a similar protocol as previously 
described with 10 µL reactions containing 1X Cutmast Buffer, 2 ng REPSAis control 
DNA, 2 ng ST2_1719_jcon-60 test DNA, and ten-fold serial dilutions of TTHA1719. 
Reactions were incubated at 55°C for 20 min and then at 37°C for 5 min before the 
addition of 0.8U FokI and a final incubation at 37°C for 5 min. The results were 
visualized using IR fluorescence and were used as a baseline to compare other REPA 
experiments in which the reaction conditions were altered. 
Because TTHA1719 contains a single cysteine residue, a reducing agent is 
needed to avoid disulfide bond formation. Another REPA was performed in the  same 
fashion as the baseline REPA but with the addition of 2 mM DTT. Four other REPA 
experiments were performed to determine if altering the reaction parameters 
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would increase or decrease the binding activity of TTHA1719. Two of these REPAs 
consisted of altering the binding temperature from 55°C to 37°C and 65°C while in the 
other two REPAs the digestion time for FokI was changed from 5 min to 7 min and 9 
minutes. All four of the REPA experiments with altered conditions were done under 
reducing conditions with 2 mM DTT and results were visualized by IR fluorescence on 


























Chapter 3.1 Protein Expression, Purification, and Quantitation of TTHA1437 and 
TTHA1719 
The TTHA1437 protein was expressed in E. coli BL21 (DE3) cells with a pET- 
11a plasmid containing the TTHA1437 gene which yielded significant protein production. 
Once expressed, the protein was purified via heat treatment at 70°C and results were 
analyzed by 12% SDS-PAGE. Each step of the expression and purification can be 
visualized in Figure 5. TTHA1437 can be observed as a strong band with a molecular 
weight of about 24 kDa, which is consistent with the literature.26 When comparing the 
soluble and purified phases, it is estimated that TTHA1437 is greater than 90% pure 
(Figure 5, lane 6). Although there are a few denatured E. coli proteins present (lane 6), 
but they are at such low concentrations that they should not affect any of our 
experimental results which has been previously observed for other Thermus thermophilus 
HB8 TFs studied in our laboratory.32,33,35,36 The identities of these remaining soluble E. 
coli proteins have yet to be determined. TTHA1437 protein quantitation was done using a 
Bradford Protein Assay and its concentration was determined to be 30.9 µM (Figure 6). 
Similarly, TTHA1719 was expressed in Rosetta 2 E. coli (DE3) cells with a pET- 
11a plasmid containing the TTHA1719 gene; TTHA1719 was expressed in Rosetta 2 due 
to its rare codon usage. The results were analyzed by 18% SDS-PAGE with 4 M urea and 
the results can be visualized in Figure 7 with TTHA1719 as a strong band in lane 4. 
TTHA1719 was determined to be greater than 60% pure which is a lower purity than 
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normally observed for other T. thermophilus HB8 TFs that have been previously studied. 
The concentration of TTHA1719 was determined using Quantitative Densitometry with 






Figure 5. Expression and purification of TTHA1437 protein. Shown is a 
12% SDS-PAGE gel stained with Coomassie Blue G-250 on which 
samples from protein expression and purification steps were analyzed. 
Lanes were loaded with samples of protein ladder (lad), logarithmic 
growth phase (log), induced and post-incubation (ind), sample after 
freeze and thaw cycle (F/T), soluble proteins following sonication (sol), 
and purified TTHA1437 following high temperature purification. 
Molecular weights of the protein ladder are indicated on the left of the 






























Figure 6. Quantitation of TTHA1437 using Bradford Protein Assay. 
Shown is the Bradford standard curve which was created by using bovine 
serum albumin (BSA) as the known standard. After the standard curve 
was established, the concentration of TTHA1437 was calculated using its 
molecular weight. The final concentration of TTHA1437 is estimated to 






















Figure 7. Expression and purification of TTHA1719 protein. Shown is 
an 18% SDS-PAGE w/ 4 M urea gel stained with Coomassie Blue G-250 
on which samples from protein expression and purification steps were 
analyzed. Lanes were loaded with samples of protein ladder (lad), 
logarithmic growth phase (log), induced and post-incubation (ind), 
soluble proteins following sonication (sol), and purified TTHA1719 
following high temperature purification. Molecular weights of the 
protein ladder are indicated on the left of the figure and the protein band 
























Figure 8. Quantitation of TTHA1719 using Quantitative Densitometry 
with Coomassie. This quantitation method also uses BSA as a standard to 
create a linear relationship, but the proteins are quantified by intensity 
rather than absorbance. Shown is the protein ladder (lad), BSA standards 
(left to right: 500 ng and 1000 ng protein), and TTHA1719. The final 





Chapter 3.2 REPSA Results for TTHA1437 and TTHA1719 
 
REPSA was used to select the TTHA1437 and TTHA1719 binding sites from a 
pool of 100 fmoles or 75 fmoles DNA selection template molecules, respectively. The 
ST2R24 selection template was used in REPSA selections for TTHA1437, while the 
ST2R35 selection template was used for TTHA1719 REPSA selections. The ST2R24 
template has previously been used to successfully identify TFs in other studies, but this is 
the first time that the ST2R35 template has been used in our laboratory for REPSA 
selections32,33,35,36. Here, TTHA1437 was subjected to two different REPSA selections in 
which one was run in the presence of 2 mM cAMP while the other was not. For 
TTHA1437 REPSA selections containing cAMP, six rounds were performed until the 
emergence of DNA resistant to IISRE cleavage (Figure 9, Round 6). In Round 6, the 
ST2R24 template DNA control (-/-) was uncut in the absence of BpmI and TTHA1437; 
the template DNA in the cleavage control (-/B) was completely cut with the presence of 
BpmI and the absence of TTA1437; the template DNA in the experimental reaction (+/B) 
was ~30% uncut in the presence of BpmI and TTHA1437 which represents the REPSA- 
selected sequences. Similarly, TTHA1437 REPSA selections were done without the 
addition of cAMP and were performed for nine rounds until IISRE cleavage resistance 
was observed in the cleavage control and experimental reaction (Figure 10, Round 9, 
lanes 2 and 3). 
TTHA1719 REPSA selections were performed for ten rounds using the ST2R35 
DNA template under reducing conditions with 1 mM DTT until ~10% of the template 
was uncut (Figure 11, Round 10, lane 3) and the internally primed asterisk species was 
greater than 40% (Figure 11, Round 10, lane 1). It is important to note that initial rounds 
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of REPSA utilized the IISRE FokI until FokI resistant DNAs emerged in the cleavage 
control at which point subsequent REPSA rounds used the IISRE BpmI to cleave the 
DNA selection templates. Typically, REPSA results are validated by REPA and EMSA 
before sequencing, but since the REPSA-selected sequences were not validated, the 




















Figure 9. REPSA selection of TTHA1437-binding sequences with 
cAMP. Shown are IR fluorescence images of restriction endonuclease 
cleavage-protection assays for Round 1 and Round 6 of REPSA 
selections with 31 nM TTHA1437 protein. Reactions in lane 1 represents 
the DNA control (-/-), lane 2 being the cleavage control containing the 
DNA template and IISRE (-/F or -/B to represent FokI and BpmI IISREs 
respectively), and lane 3 is the experimental reaction containing DNA 
template, IISRE, and TTHA1437 (+/F or +/B). Band designations: (T) 
intact ST2R24 selection template, (X) cleaved ST2R24 selection 





Figure 10. REPSA selection of TTHA1437-binding sequences without 
cAMP. Shown are IR fluorescence images of restriction endonuclease 
cleavage-protection assays for Round 1 and Round 9 of REPSA 
selections with 31 nM TTHA1437 protein. Reactions in lane 1 represents 
the DNA control (-/-), lane 2 being the cleavage control containing the 
DNA template and IISRE (-/F or -/B to represent FokI and BpmI IISREs 
respectively), and lane 3 is the experimental reaction containing DNA 
template, IISRE, and TTHA1437 (+/F or +/B). Band designations: (T) 
intact ST2R24 selection template, (A) internally primed asterisk species, 




Figure 11. REPSA selection of TTHA1719-binding sequences. Shown are 
IR fluorescence images of restriction endonuclease cleavage-protection 
assays for Round 1 and Round 10 of REPSA selections with 42 nM 
TTHA1719 protein. Reactions in lane 1 represents the DNA control (-/-), 
lane 2 being the cleavage control containing the DNA template and IISRE 
(-/F or -/B to represent FokI and BpmI IISREs respectively), and lane 3 is 
the experimental reaction containing DNA template, IISRE, and 
TTHA1437 (+/F or +/B). Band designations: (T) intact ST2R35 selection 
template, (A) internally primed asterisk species, (X) cleaved ST2R35 
selection template, and (P) IRD7_ST2R primer. 
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Chapter 3.3 Validation of REPSA Results via REPA and EMSA 
Following REPSA selections for TTHA1437 and TTHA1719, the selected DNA 
species were attempted to be validated using both REPA and EMSA, but both were 
unsuccessful. REPA was performed to determine whether specific or nonspecific DNA-
binding interactions occurred between TTHA1437 and the ST2R24 template (Figure 
12A) or TTHA1719 and the ST2R35 template (Figure 12B). REPA utilizes a fluorescent 
green-labeled DNA probe, REPSAis, which contains a defined DNA template, the 
REPSA-selected DNAs (Round 6 or Round 10, respectively), and the respective IISRE. 
Since no REPSA-selected DNAs were observed for TTHA1437 without cAMP, no 
REPA was performed. The REPA results for TTHA1437 indicate nonspecific binding 
due to TTHA1437-REPSAis binding interactions. 
Contrarily, the REPA results for TTHA1719 do not indicate any binding interactions at 
all, specific or nonspecific, since both the cleavage control and experimental reactions do 
not show any protein-DNA interactions. 
In addition to REPA, EMSA was used to validate REPSA selections which would 
typically quantify the affinity of the TF for the selected DNAs. Ten-fold dilutions of 
TTHA1437 and TTHA1719 with their respective selected DNAs did now show any 
protein-DNA complex formation which indicates that the protein is not binding to any or 







Figure 12. Attempt to validate TTHA1437 and TTHA1719 DNA-binding 
sequences with REPA. (A) Shown is an IR fluorescence image of restriction 
endonuclease protection assay with ST2R24 DNAs selected from Round 6 of 
REPSA for TTHA1437 with cAMP. (B) Shown is an IR fluorescence image of 
REPA with ST2R35 DNAs selected from Round 10 of REPSA for TTHA1719. 
The presence (+) or absence (-) of protein (TTHA1437 or TTHA1719 
respectively) and IISRE BpmI (B) are denoted above each lane. Band 
designations: (T) intact and (X) cleaved IRD7-labeled ST2R24 or ST2R35 
































Figure 13. Attempt to validate TTHA1437 and TTHA1719 DNA-binding sequences with EMSA. (A) Shown is an IR 
fluorescence image of electrophoretic mobility shift assay with ST2R24 DNAs selected from Round 6 of REPSA for TTHA1437 
with cAMP incubated with increasing concentrations of TTHA1437 protein (from left to right: 0, 3.09, 30.9 309 and 3,090 nM 
TTHA1437). (B) Shown is an IR fluorescence image of EMSA with ST2R35 DNAs selected from Round 10 of REPSA for 
TTHA1719 incubated with increasing concentrations of TTHA1719 protein (from left to right: 0, 4.16, 41.6, 416, and 4,160 nM 
TTHA1719). (C) indicates the DNA control in the absence of protein. 
C C 
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Chapter 3.4 Analysis of Proposed and Known Consensus DNAs with Binding Assays 
Prior to REPSA selections with TTHA1719, the proposed consensus sequence for 
its binding site was subjected to multiple REPAs to determine the optimal protocol 
conditions which were later used in REPSA selections.28 These assays were done prior to 
REPSA selections due to TTHA1719’s low molecular weight and its tetrameric binding 
activity. The initial REPA was performed under standard and unaltered conditions to 
create baseline data to compare altered REPA experiments to (Figure 14). The REPA 
experiments with altered reaction conditions are as follows: addition of a reducing agent 
(1 mM DTT), increased digestion time for IISRE (7 and 9 min), and altered incubation 
temperature for TF binding (37°C or 65°C); Figures 15-19. The results of these 
preliminary experiments demonstrated that the reaction conditions to be used in REPSA 
selections for TTHA1719 were the addition of 1 mM DTT, 9 min digestion time with 
IISRE FokI or BpmI, and an incubation temperature of 55°C to allow protein-DNA 
complex formation. 
Additionally, EMSA and BLI were performed for the E. coli CRP consensus 
sequence with TTHA1437 following REPSA selections. These assays were done after 
REPSA selections and validation since the REPA results showed nonspecific binding and 
the EMSA results did not show any protein-DNA complex formation (Figure 20). The E. 
coli CRP consensus DNA was chosen for these assays since TTHA1437 belongs to the 
CRP/FNR class of TFs in T. thermophilus HB8 and is speculated to be homologous to the 
E. coli CRP in function and/or structure.20,22 Unfortunately, the results of EMSA with the 
CRP consensus sequence and TTHA1437 did not show any protein-DNA complex 
formation. The BLI results also showed no binding activity when the real-time kinetics 
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were observed with TTHA1437 concentrations of 11, 33, 100 and 300 nM (Figure 21). 
No BLI was done with our control DNA, REPSAis, since there BLI results between 













































Figure 14. Baseline REPA with proposed consensus and TTHA1719. Shown 
is an IR fluorescence image of restriction endonuclease protection assay with 
ST2_1719_jcon-60 and TTHA1719. (DC) denotes DNA control, (CC) 
denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE FokI. 
TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 4160 
nM. Band designations: (T) intact and (X) cleaved IRD7-labeled 













































Figure 15. Experimental REPA with a reducing agent. Shown is an IR 
fluorescence image of restriction endonuclease protection assay with 
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA 
control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE 
FokI. TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 
4160 nM. Band designations: (T) intact and (X) cleaved IRD7-labeled 





































Figure 16. Experimental REPA with 7 min IISRE digestion time. 
Shown is an IR fluorescence image of restriction endonuclease 
protection assay with ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. 
(DC) denotes DNA control, (CC) denotes the cleavage control. Lanes 2- 
6 contain 0.4 U IISRE FokI. TTHA1719 concentrations from left to 
right are 4.16, 41.6, 416, and 4160 nM. Band designations: (T) intact 
and (X) cleaved IRD7-labeled ST2_1719_jcon-60 DNA template (red) 







































Figure 17. Experimental REPA with 9 min IISRE digestion time. Shown is an 
IR fluorescence image of restriction endonuclease protection assay with 
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA control, 
(CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE FokI. 
TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 4160 nM. 
Band designations: (T) intact and (X) cleaved IRD7-labeled ST2_1719_jcon- 









































Figure 18. Experimental REPA with 37°C binding temperature. Shown is 
an IR fluorescence image of restriction endonuclease protection assay with 
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA 
control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE 
FokI. TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 
4160 nM. Band designations: (T) intact and (X) cleaved IRD7-labeled 
ST2_1719_jcon-60 DNA template (red) and IRD8-labeled REPSAis 








































Figure 19. Experimental REPA with 65°C binding temperature. Shown 
is an IR fluorescence image of restriction endonuclease protection assay 
with ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes 
DNA control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4 
U IISRE FokI. TTHA1719 concentrations from left to right are 4.16, 
41.6, 416, and 4160 nM. Band designations: (T) intact and (X) cleaved 
IRD7-labeled ST2_1719_jcon-60 DNA template (red) and IRD8- 




















Figure 20. Investigation of TTHA1437-CRP consensus interactions 
with EMSA. Shown is an IR fluorescence image of electrophoretic 
mobility shift assay with IRD7-labeled ST2_CRP_Ec DNA and 
TTHA1437. The reactions were run with 2 mM cAMP and the running 
buffer was supplemented with cAMP to a final concentration of 2 mM. 












Figure 21. BLI raw data plot of TTHA1719-CRP consensus binding. 
Shown is the biolayer interferometry data between TTHA1719 and the 
E. coli consensus DNA. Binding kinetics were observed over 1200 sec 
with TTHA1437 concentrations of 11, 33, 100, and 300 nM. The BLI 
100 buffer was supplemented with cAMP to a final concentration of 2 
mM. Since no association or dissociation steps were observed, no KD 








In these studies, the combinatorial selection method Restriction Endonuclease 
Protection, Selection, and Amplification (REPSA), was used to determine if DNA- 
binding interactions occurred between our ST2R24 selection template and TTHA1417 as 
well as the ST2R35 selection template and TTHA1719. Although TTHA1417 showed a 
~30% protected DNA pool and TTHA1719 showed ~10% protected DNA pool when the 
results were verified using Restriction Endonuclease Protection Assay (REPA) and 
Electrophoretic Mobility Shift Assay (EMSA) the selected species were either deemed as 
nonspecific binding or not able to be validated using these methods. As mentioned 
previously, using EMSA to validate TTHA1437-DNA interactions was not a preferred 
method due to its proposed need for the effector molecule cAMP. 
The preliminary REPA binding assays with the proposed consensus DNA for 
TTHA1719 proved to be promising with the amount of protected DNA species, but this 
was only used to establish optimal protocol conditions for REPSA selections with 
TTHA1719. If time allowed, it would have been beneficial to run other binding assays 
such as EMSA to determine the percentage of DNA-protein complexes as well as 
Biolayer Interferometry (BLI) to ascertain the binding kinetics. 
Although our REPSA method has worked for previously studied Thermus 
thermophilus HB8 transcription factors in our laboratory, REPSA was not successful in 
identifying the DNA-binding consensus sequence for both TTHA1417 and TTHA1719. 
This demonstrates that this method is not viable for identifying and characterizing all TFs 
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in T. thermophilus HB8. As previously stated, TTHA1417 belongs to the CRP/FNR 
family of activators in this organism and has been proposed to be a cAMP receptor 
protein with possible homology to E. coli CRP. It is possible that TTHA1437 is not a 
local regulator, but a global regulator like that of E. coli CRP. If this is the case, the 
REPSA method would not be able to identify a consensus DNA-binding sequence for 
TTHA1437 due to many factors such as co-regulation, dual regulation and a possible 
DNA-binding domain that is not highly specific. 
TTHA1719 is a copper-sensing transcriptional repressor (CsoR) which is 
speculated to only regulate a single operon, the copper-sensitive operon. Using REPAS to 
identify a TF which regulates only a single operon would be extremely difficult since its 
DNA-binding sequence would be extremely specific to that transcription factor. In the 
past, TFs characterized by REPSA have traditionally been thought to regulate more than 
a single operon, with most potentially regulating multiple. Although REPSA was unable 
to identify and characterize the DNA-binding sites of TTHA1437 and TTHA1719 and 
their potential biological functions, these studies show that the REPSA method can in fact 






APPENDIX: FUTURE DIRECTIONS 
 
Future directions include further investigation of the TTHA1719 proposed 
consensus sequence as well as the investigation of the asterisk species found in REPSA 
selections with both ST2R24 and TTHA1437 as well as ST2R35 and TTHA1719. The 
asterisk species has rarely been observed and its sequence is highly unknown. It is a 
truncated DNA species that is caused by internal priming in the randomized region of the 
selection template. Interestingly, the asterisk species became visible and amplified more 
rapidly with the ST2R35 template than the ST2R24 template, so it is quite possible that 
the length of the internal randomized region plays a role in asterisk species formation. 
Sequencing these rare DNA species would determine if the asterisk species from different 
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